Functions of natural killer cells
The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Abstract
Natural killer (NK) cells are effector lymphocytes of the innate immune system that control several types of tumors and microbial infections by limiting their spread and subsequent tissue damage. Recent research highlights the fact that NK cells are also regulatory cells engaged in reciprocal interactions with dendritic cells, macrophages, T cells and endothelial cells. NK cells can thus limit or exacerbate immune responses. Although NK cells might appear to be redundant in several conditions of immune challenge in humans, NK cell manipulation seems to hold promise in efforts to improve hematopoietic and solid organ transplantation, promote antitumor immunotherapy and control inflammatory and autoimmune disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, myofibroblasts that fail to enter senescence and continue to produce scar tissue are resistant to NK activity and perpetuate fibrosis even after the inflammatory stimulus has reduced.84,85”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [84]
Citations
Cites
The biology of human natural killer-cell subsets
Cooper, M. A., Fehniger, T. A., & Caligiuri, M. A. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02060-9 · Cited by 2,975 · cited 1×
“In humans, NK cells can be divided into CD56 dim and CD56 bright NK cell subsets, which differ in their homing propertie”
BackgroundBiology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902 · cited 1×
“NK cells were later recognized as a separate lymphocyte lineage, with both cytotoxicity and cytokine-producing effector function”
BackgroundLanier, L. L. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,769 · cited 1×
“Activating NK cell receptors detect the presence of ligands on cells in 'distress', such as the stress-induced self ligands recognized by NKG2D (human ULBP and MIC molecules, as well as mouse RAE1, H60 and MULT1 molecules”
BackgroundSelective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
Kärre, K., Ljunggren, H. G., Piontek, G., & Kiessling, R. (1986) · Nature · doi:10.1038/319675a0 · Cited by 2,161 · cited 1×
“As a consequence, NK cells have been described as able to recognize 'missing self' on hematopoietic cell”
BackgroundNATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate Cytokines
Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P., & Salazar-Mather, T. P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.189 · Cited by 2,113 · cited 1×
“, whereas chemokines such as CCL3 (MIP-1α), CXCL10 (IP-10) and CXCL9 (MIG) coordinately regulate NK cell traffickin”
BackgroundMiller, J. S., Soignier, Y., Panoskaltsis-Mortari, A., McNearney, S. A., Yun, G. H., Fautsch, S. K., McKenna, D., Le, C., Defor, T. E., Burns, L. J., et al. (2005) · Blood · doi:10.1182/blood-2004-07-2974 · Cited by 1,903 · cited 1×
“, and NK cell–mediated therapy after hematopoietic cell transplantation seems saf”
BackgroundDecidual NK cells regulate key developmental processes at the human fetal-maternal interface
Hanna, J., Goldman-Wohl, D., Hamani, Y., Avraham, I., Greenfield, C., Natanson-Yaron, S., Prus, D., Cohen-Daniel, L., Arnon, T. I., Manaster, I., et al. (2006) · Nature Medicine · doi:10.1038/nm1452 · Cited by 1,681 · cited 1×
“uNK represent a very distinct subset of NK cells that secrete proangiogenic factors such as vascular endothelial growth factor (VEGF), placental growth factor (PLGF) and NKG5 (ref”
BackgroundInduced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming
Martín-Fontecha, A., Thomsen, L. L., Brett, S., Gerard, C., Lipp, M., Lanzavecchia, A., & Sallusto, F. (2004) · Nature Immunology · doi:10.1038/ni1138 · Cited by 1,353
Licensing of natural killer cells by host major histocompatibility complex class I molecules
Kim, S., Poursine-Laurent, J., Truscott, S. M., Lybarger, L., Song, Y.-J., Yang, L., French, A. R., Sunwoo, J. B., Lemieux, S., Hansen, T. H., et al. (2005) · Nature · doi:10.1038/nature03847 · Cited by 1,340 · cited 1×
“This education process requires the recognition of self–MHC class I molecules by cognate inhibitory receptors, such as Ly49 molecules in mice and KIRs in human”
BackgroundDirect Recognition of Cytomegalovirus by Activating and Inhibitory NK Cell Receptors
Arase, H., Mocarski, E. S., Campbell, A. E., Hill, A. B., & Lanier, L. L. (2002) · Science · doi:10.1126/science.1070884 · Cited by 1,230
Research works printed but not linked: 1
- Stewart, C.A. & Vivier, E. Strategies of NK cell recognition and their roles in tumor immunosurveillance. in How the Immune System Recognizes Self and Nonself: Immunoreceptors and Their Signaling (ed. Kitamura, D.) 37–81 (Springer, Tokyo, 2007).
Cited by
Items 301–400 of 1,008
Low-dose IL-2 selectively activates subsets of CD4+ Tregs and NK cells
Hirakawa, M., Matos, T. R., Liu, H., Koreth, J., Kim, H. T., Paul, N. E., Murase, K., Whangbo, J., Alho, A. C., Nikiforow, S., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.89278 · Cited by 151
“CD56brightCD16– NK cells can also differentiate into CD56dimCD16+ NK cells under appropriate conditions (55, 57).”
BackgroundDavis, Z., Vallera, D. A., Miller, J. S., & Felices, M. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.07.011 · Cited by 150
“These innate lymphocytes are large and granular in their morphology, with the large granules present in their cytoplasm containing the cellular machinery necessary to perforate and induce apoptosis of susceptible targets[2].”
BackgroundAbsi, A. A., Wurzer, H., Guérin, C. L., Hoffmann, C., Moreau, F., Mao, X., Brown-Clay, J. D., Petrolli, R., Casellas, C. P., Dieterle, M., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0441 · Cited by 150
Cell‐Based Delivery Systems: Emerging Carriers for Immunotherapy
Li, Z., Wang, Y., Ding, Y., Repp, L., Kwon, G. S., & Hu, Q. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202100088 · Cited by 146
Lamarthée, B., Callemeyn, J., Herck, Y. V., Antoranz, A., Anglicheau, D., Boada, P., Becker, J. U., Debyser, T., Smet, F. D., Vusser, K. D., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39859-7 · Cited by 153
“Among NK cells, Fc γ RIII+ NK cells represent a cytotoxic subset, whereas Fc γ RIII-NK cells harness more regulatory functions 37 .”
Klöß, S., Oberschmidt, O., Morgan, M., Dahlke, J., Arseniev, L., Huppert, V., Granzin, M., Gardlowski, T., Matthies, N., Soltenborn, S., et al. (2017) · Human Gene Therapy · doi:10.1089/hum.2017.157 · Cited by 136
Symphony of nanomaterials and immunotherapy based on the cancer–immunity cycle
Li, Q., Shi, Z., Zhang, F., Zeng, W., Zhu, D., & Mei, L. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.05.031 · Cited by 138
Vidal, S. M., Khakoo, S. I., & Biron, C. A. (2011) · Current Opinion in Virology · doi:10.1016/j.coviro.2011.10.017 · Cited by 147
Yvon, E. S., Burga, R. A., Powell, A. B., Cruz, C. C., Fernandes, R., Barese, C. N., Nguyen, T., Abdelbaki, M. S., & Bollard, C. M. (2017) · Cytotherapy · doi:10.1016/j.jcyt.2016.12.005 · Cited by 135
Role of NKG2D and its ligands in cancer immunotherapy.
Liu, H., Wang, S., Xin, J., Wang, J., Yao, C., & Zhang, Z. (2019) · PubMed · Cited by 179
Human NK cells: From development to effector functions
Arachchige, A. S. P. M. (2020) · Innate Immunity · doi:10.1177/17534259211001512 · Cited by 163
“It has also been suggested that human NK cells could cause vascular injury due to their expression of receptors for endothelial cell adhesion molecules that can be activated by endothelial membrane ligands such as CX3CL1.”
BackgroundGenome-wide expression profile of first trimester villous and extravillous human trophoblast cells
Apps, R., Sharkey, A., Gardner, L., Male, V. H., Trotter, M. W. B., Miller, N. G. A., North, R. A., Founds, S. A., & Moffett, A. (2010) · Placenta · doi:10.1016/j.placenta.2010.10.010 · Cited by 138
“Leukocyte receptor complex genes LILRB1, LILRB3 and LAIR-1 are typically expressed on leukocytes and are all important in regulation of NK cell function [7].”
BackgroundWhat Defines NK Cell Functional Fate: Phenotype or Metabolism?
Poznanski, S. M., & Ashkar, A. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01414 · Cited by 158
“Natural Killer (NK) immune cells are capable of an array of functions that range widely from their classic innate anti-tumor and anti-viral effector functions, to their regulatory roles in modulating other immune cells and promoting tissue growth (1).”
BackgroundUnleashing Natural Killer Cells in the Tumor Microenvironment–The Next Generation of Immunotherapy?
Ben‐Shmuel, A., Biber, G., & Barda‐Saad, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00275 · Cited by 147
“NK cells are cytotoxic innate lymphoid cells (ILCs), which can target and eliminate cancer cells through secretion of cytolytic granules, and trigger an immune response via secretion of immunomodulatory cytokines (4).”
BackgroundMendoza, M. S., & Morales‐Montor, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00348 · Cited by 149
“ER in NK Cells NK cells are central components of the innate immunity and they participate in preventing and controlling infections and tumor growth and metastasis (115).”
BackgroundChiba, A., Tajima, R., Tomi, C., Miyazaki, Y., Yamamura, T., & Miyake, S. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33314 · Cited by 133
Innate immune mediators in cancer: between defense and resistance
Berraondo, P., Minute, L., Ajona, D., Corrales, L. P., Melero, I., & Pío, R. (2016) · Immunological Reviews · doi:10.1111/imr.12464 · Cited by 147
Dosani, T., Carlsten, M., Maric, I., & Landgren, O. (2015) · Blood Cancer Journal · doi:10.1038/bcj.2015.32 · Cited by 147
Favier, B., LeMaoult, J., Lesport, E., & Carosella, E. D. (2009) · The FASEB Journal · doi:10.1096/fj.09-135194 · Cited by 146
“Natural killer (NK) cells are a subset of lymphocytes involved in tumoral and viral immune responses (1, 2).”
BackgroundNAKAYAMA, M., Takeda, K., Kawano, M., Takai, T., Ishii, N., & Ogasawara, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110584108 · Cited by 137
“However, NK cells can also negatively regulate adaptive immune responses (2, 5).”
BackgroundAnnamalai, T., Saif, L. J., Lu, Z., & Jung, K. (2015) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2015.09.006 · Cited by 148
“NK cells are also a major source of certain cytokines such as IFN␥ and TNF␣ (Fauriat et al., 2010; Vivier et al., 2008) .”
BackgroundJuliá, E. P., Amante, A., Pampena, M. B., Mordoh, J., & Levy, E. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02140 · Cited by 139
“Mature NK cells express at least one inhibitory receptor specific for selfMHC class I molecules (MHC-I) as a protective mechanism, repressing NK-cell activation against non-transformed cells (27, 30).”
BackgroundLo, H. C., Xu, Z., Kim, I. S., Pingel, B. C., Aguirre, S., Kodali, S., Liu, J., Zhang, W., Muscarella, A. M., Hein, S., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0068-9 · Cited by 143
NK cell exhaustion in the tumor microenvironment
Hao, J., Yang, H., Xiong, H., & Luo, K. Q. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1303605 · Cited by 160
CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain–engineered monoclonal antibody
Awan, F. T., Lapalombella, R., Trotta, R., Butchar, J. P., Yu, B., Benson, D. M., Roda, J. M., Cheney, C., Mo, X., Lehman, A., et al. (2010) · Blood · doi:10.1182/blood-2009-06-229039 · Cited by 131
Dopaminergic Regulation of Innate Immunity: a Review
Pinoli, M., Marino, F., & Cosentino, M. (2017) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-017-9749-2 · Cited by 137
Baci, D., Bosi, A., Gallazzi, M., Rizzi, M., Noonan, D. M., Poggi, A. D., Bruno, A., & Mortara, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093125 · Cited by 147
Theranostic cells: emerging clinical applications of synthetic biology
McNerney, M. P., Doiron, K. E., Ng, T. L., Chang, T. Z., & Silver, P. A. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00383-3 · Cited by 141
Natural Killer Cells: Key Players in Endometriosis
Thiruchelvam, U., Wingfield, M. B., & O’Farrelly, C. (2015) · American Journal of Reproductive Immunology · doi:10.1111/aji.12408 · Cited by 145
Next-Generation Chimeric Antigen Receptor T-Cell Therapy: Going off the Shelf
Ruella, M., & Kenderian, S. S. (2017) · BioDrugs · doi:10.1007/s40259-017-0247-0 · Cited by 136
“They do not require HLA matching and can be used as allogeneic effector cells [39].”
BackgroundMuter, J., Lynch, V. J., McCoy, R. C., & Brosens, J. J. (2023) · Development · doi:10.1242/dev.201507 · Cited by 147
Differential Requirement for Nfil3 during NK Cell Development
Seillet, C., Huntington, N. D., Gangatirkar, P., Axelsson, E., Minnich, M., Brady, H. J. M., Busslinger, M., Smyth, M. J., Belz, G. T., & Carotta, S. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302605 · Cited by 128
“Functionally, TRAIL+ NK cells are poor secretors of IFN-g and IL-13, and they were reported to possess memory-like properties (10, 11).”
BackgroundNK cells exacerbate the pathology of influenza virus infection in mice
Zhou, G., Juang, S. W. W., & Kane, K. P. (2013) · European Journal of Immunology · doi:10.1002/eji.201242620 · Cited by 140
Victorino, F., Sojka, D. K., Brodsky, K. S., McNamee, E. N., Masterson, J. C., Homann, D., Yokoyama, W. M., Eltzschig, H. K., & Clambey, E. T. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500651 · Cited by 131
Targeting myeloid cells in the tumor sustaining microenvironment
Schupp, J., Krebs, F. K., Zimmer, N., Trzeciak, E., Schuppan, D., & Tuettenberg, A. (2019) · Cellular Immunology · doi:10.1016/j.cellimm.2017.10.013 · Cited by 126
Natural Killer Cells in the Lungs
Cong, J., & Wei, H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01416 · Cited by 140
“As a type of innate immune cell, natural killer (NK) cells are regarded as the host’s first line of defense against tumors and viral infection (2).”
BackgroundModulation of tumor microenvironment for immunotherapy: focus on nanomaterial-based strategies
Liu, Y., Guo, J., & Huang, L. (2020) · Theranostics · doi:10.7150/thno.42998 · Cited by 135
“The NK cells release IFN-γ to promote the expression levels of MHC-I on cancer cells and MHC-II on APCs, facilitating the connection of innate and adaptive immunities [44].”
BackgroundPeripheral Blood NK Cells from Breast Cancer Patients Are Tumor-Induced Composite Subsets
Mamessier, É., Pradel, L. C., Thibult, M., Drevet, C., Zouine, A., Jacquemier, J. D., Houvenaeghel, G. F., Bertucci, F., Birnbaum, D., & Olive, D. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1200140 · Cited by 140
“N atural killer cells are innate immune cells specialized in the detection and clearance of “modified-self,” such as cancer cells (1).”
BackgroundFeatures of Human Decidual NK Cells in Healthy Pregnancy and During Viral Infection
Jabrane‐Ferrat, N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01397 · Cited by 139
SARS-CoV-2 Spike 1 Protein Controls Natural Killer Cell Activation via the HLA-E/NKG2A Pathway
Bortolotti, D., Gentili, V., Rizzo, S., Rotola, A., & Rizzo, R. (2020) · Cells · doi:10.3390/cells9091975 · Cited by 89
“are important effectors in antitumor and anti-infection immunity [9].”
BackgroundNatural killer cells: diversity in search of a niche
Santo, J. P. D. (2008) · Nature Immunology · doi:10.1038/ni.f.201 · Cited by 134
Two Novel Human Cytomegalovirus NK Cell Evasion Functions Target MICA for Lysosomal Degradation
Fielding, C. A., Aicheler, R., Stanton, R. J., Wang, E. C. Y., Han, S., Seirafian, S., Davies, J. A., McSharry, B. P., Weekes, M. P., Antrobus, R., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004058 · Cited by 146
“The activating receptor NKG2D is remarkable in being expressed ubiquitously on all NK cells and capable of recognizing at least 8 distinct ligands: the major histocompatibility complex class I (MHC-I) chain-related molecules (MICA and MICB) and the UL16-binding proteins 1–6 (ULBP1-ULBP6) [41,42,43].”
BackgroundNatural Killer Cell Response to Chemotherapy-Stressed Cancer Cells: Role in Tumor Immunosurveillance
Zingoni, A., Fionda, C., Borrelli, C., Cippitelli, M., Santoni, A., & Soriani, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01194 · Cited by 125
“The anticancer immune response: indispensable for therapeutic success? J Clin Invest (2008) 118(6):1991–2001.”
BackgroundTargeting T cell malignancies using CAR-based immunotherapy: challenges and potential solutions
Fleischer, L. C., Spencer, H. T., & Raikar, S. S. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0801-y · Cited by 135
Berrien-Elliott, M. M., Foltz, J. A., Russler‐Germain, D. A., Neal, C. C., Tran, J., Gang, M., Wong, P., Fisk, B. A., Cubitt, C. C., Marín, N. D., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abm1375 · Cited by 140
“NK cells are innate lymphoid cells that play key roles in defense against pathogens and antitumor immune responses (6).”
BackgroundDecreased Cytotoxicity of Peripheral and Peritoneal Natural Killer Cell in Endometriosis
Jeung, I. C., Cheon, K., & Kim, M.-R. (2016) · BioMed Research International · doi:10.1155/2016/2916070 · Cited by 136
“The cells have both cytolytic and immunomodulatory capabilities [27, 28].”
BackgroundPan, Y., Tang, W., Fan, W., Zhang, J., & Chen, X. S. (2022) · Chemical Society Reviews · doi:10.1039/d1cs01145f · Cited by 131
Baessler, T., Charton, J. E., Schmiedel, B. J., Grünebach, F., Krusch, M., Wacker, A., Rammensee, H., & Salih, H. R. (2009) · Blood · doi:10.1182/blood-2009-06-227934 · Cited by 139
Wang, F., Meng, M., Mo, B., Yang, Y., Ji, Y., Huang, P., Lai, W., Pan, X., You, T., Luo, H., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07277-9 · Cited by 133
Neutrophil activation and survival are modulated by interaction with NK cells
Costantini, C., Micheletti, A., Calzetti, F., Perbellini, O., Pizzolo, G., & Cassatella, M. A. (2010) · International Immunology · doi:10.1093/intimm/dxq434 · Cited by 140
Cicchini, L., Westrich, J. A., Xu, T., Vermeer, D. W., Berger, J., Clambey, E. T., Lee, D., Song, J. I., Lambert, P. F., Greer, R. O., et al. (2016) · mBio · doi:10.1128/mbio.00270-16 · Cited by 133
The Adhesion G Protein-Coupled Receptor GPR56/ADGRG1 Is an Inhibitory Receptor on Human NK Cells
Chang, G.-W., Hsiao, C.-C., Peng, Y.-M., Vieira Braga, F. A., Kragten, N. A. M., Remmerswaal, E. B. M., van de Garde, M. D. B., Straussberg, R., König, G. M., Kostenis, E., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.053 · Cited by 124
“Upon target cell encounter, differentiated CD56 NK cells produce large amounts of cytokines, chemokines, and cytolytic proteins, similar to effector-type CD8 T cells (Fauriat et al., 2010; Nagler et al., 1989; Vivier et al., 2008).”
BackgroundRatajczak, W., Niedźwiedzka‐Rystwej, P., Tokarz–Deptuła, B., & Deptuła, W. (2018) · Central European Journal of Immunology · doi:10.5114/ceji.2018.77390 · Cited by 156
“Due to their ability to release inflammatory cytokines, growth factors, and chemokines NK cells can kill infected and neoplastically transformed cells [93-95].”
BackgroundIgG and Fcγ Receptors in Intestinal Immunity and Inflammation
Castro‐Dopico, T., & Clatworthy, M. R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00805 · Cited by 144
“Their cytotoxic counterparts, NK cells, express activating FcγRIIC and FcγRIIIA in humans, and FcγRIII in mice, but not FcγRIIB (195, 196).”
BackgroundClonal hematopoiesis and inflammation: Partners in leukemogenesis and comorbidity
Cook, E. K., Luo, M., & Rauh, M. J. (2020) · Experimental Hematology · doi:10.1016/j.exphem.2020.01.011 · Cited by 121
Immunological Basis of the Endometriosis: The Complement System as a Potential Therapeutic Target
Agostinis, C., Balduit, A., Mangogna, A., Zito, G., Romano, F., Ricci, G., Kishore, U., & Bulla, R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.599117 · Cited by 124
You, L., Cha, S., Kim, M., & Cho, J. Y. (2021) · Journal of Ginseng Research · doi:10.1016/j.jgr.2021.12.007 · Cited by 139
“NK cells, which comprise a minor part of total lymphocytes, are distributed in both lymphoid and nonlymphoid tissues [31,34].”
BackgroundMukaida, N., Sasaki, S., & Baba, T. (2014) · Mediators of Inflammation · doi:10.1155/2014/170381 · Cited by 136
“Natural killer (NK) cells are unconventional lymphocytes, which can in vitro kill a broad range of tumor cells of both hematopoietic and nonhematopoietic origin by utilizing perforin and secreting interferon (IFN)-γ [32].”
BackgroundA Randomized Placebo-Controlled Trial of Massage Therapy on the Immune System of Preterm Infants
Ang, J. Y., Lua, J. L., Mathur, A., Thomas, R. G., Asmar, B. I., Savaşan, S., Buck, S. A., Long, M., & Shankaran, S. (2012) · PEDIATRICS · doi:10.1542/peds.2012-0196 · Cited by 123
Adaptive NK Cells Resist Regulatory T-cell Suppression Driven by IL37
Sarhan, D., Hippen, K. L., Lemire, A., Hying, S., Luo, X., Lenvik, T., Curtsinger, J., Davis, Z., Zhang, B., Cooley, S., et al. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0498 · Cited by 121
“Natural killer (NK) cells are innate immune effectors capable of fighting viral infections and cancer (1).”
BackgroundEffect of Natural Compounds on NK Cell Activation
Grudzień, M., & Rapak, A. (2018) · Journal of Immunology Research · doi:10.1155/2018/4868417 · Cited by 139
“An indirect recognition mechanism called ADCC (antibody-dependent cellular cytotoxicity) utilizes the ability to express the FcγRIIIa receptor (CD16) by NK cells, which in turn enables antibody-coated target cell detection [4].”
BackgroundGarcía‐Broncano, P., Maddali, S., Einkauf, K. B., Jiang, C., Gao, C., Chevalier, J. M., Chowdhury, F. Z., Maswabi, K., Ajibola, G., Moyo, S. M., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aax7350 · Cited by 133
“CD56dim CD16− NK cells, primarily recognized as abundant cytokine producers (32), were also significantly increased in the EIT group (P = 0.”
BackgroundAntibody and antibody fragments for cancer immunotherapy
Chen, W., Yang, Y., & Jiang, X. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.08.021 · Cited by 129
Wenzek, C., Boelen, A., Westendorf, A. M., Engel, D. R., Moeller, L. C., & Führer-Sakel, D. (2022) · European Journal of Endocrinology · doi:10.1530/eje-21-1171 · Cited by 136
Altered functions of natural killer cells in response to L-Arginine availability
Lamas, B., Vergnaud, J., Gonçalves-Mendes, N., Perche, O., Rossary, A., Vasson, M., & Farges, M. (2012) · Cellular Immunology · doi:10.1016/j.cellimm.2012.11.018 · Cited by 136
Alteration of Natural Killer cell phenotype and function in obese individuals
Viel, S., Besson, L., Charrier, E., Marçais, A., Disse, E., Bienvenu, J., Walzer, T., & Dumontet, C. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.01.007 · Cited by 135
Self-citationProstaglandin E2 As a Modulator of Viral Infections
Sander, W. J., O’Neill, H. G., & Pohl, C. H. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00089 · Cited by 129
“Adapted from Rouse and Sehrawat (2010). preventing spread to neighboring cells (Vivier et al., 2008).”
BackgroundB7-H6/NKp30 interaction: a mechanism of alerting NK cells against tumors
Kaifu, T., Escalière, B., Gastinel, L. N., Vivier, É., & Baratin, M. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0802-7 · Cited by 138
“First described as ‘‘killer lymphocytes with undefined nature’’, they are now recognized as very sophisticated effectors, playing a key role in innate immunity and in the orchestration of the adaptive immunity in response to allogeneic, transformed, as well as infected cells [3].”
Self-citationNatural killer cells and liver fibrosis
Fasbender, F., Widera, A., Hengstler, J. G., & Watzl, C. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00019 · Cited by 118
“Additionally, they regulate adaptive immune responses via contact-dependent signals and the secretion of cytokines (1).”
BackgroundImmune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it?
Boasso, A., Shearer, G. M., & Chougnet, C. A. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.02043.x · Cited by 147
Costantini, C., Calzetti, F., Perbellini, O., Micheletti, A., Scarponi, C., Lonardi, S., Pelletier, M., Schakel, K., Pizzolo, G., Facchetti, F., et al. (2011) · Blood · doi:10.1182/blood-2010-06-287243 · Cited by 117
NK Cells and Their Ability to Modulate T Cells during Virus Infections
Cook, K. D., Waggoner, S. N., & Whitmire, J. K. (2014) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2014010604 · Cited by 133
“Broadly speaking, NK cells are activated by three distinct processes: (1) soluble factors including interferons and other cytokines, (2) elevated expression of activating ligands or reduced levels of inhibitory ligands on accessory or target cells, and (3) infectionassociated antigens that directly bind NK cell recept…”
BackgroundGenetics, genomics, and evolutionary biology of NKG 2D ligands
Carapito, R., & Bahram, S. (2015) · Immunological Reviews · doi:10.1111/imr.12328 · Cited by 130
Pötzl, J., Roser, D., Bankel, L., Hömberg, N., Geishauser, A., Brenner, C. D., Weigand, M., Röcken, M., & Mocikat, R. (2017) · International Journal of Cancer · doi:10.1002/ijc.30646 · Cited by 119
Bruno, A., Bassani, B., D’Urso, D. G., Pitaku, I., Cassinotti, E., Pelosi, G., Boni, L., Dominioni, L., Noonan, D. M., Mortara, L., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201701103r · Cited by 129
“NK cellsmay control both primary tumor growth and metastases (3, 7); however, NK cells in patients with cancer are compromised in their cytotoxic activity (8–10).”
BackgroundRafei, H., Daher, M., & Rezvani, K. (2020) · British Journal of Haematology · doi:10.1111/bjh.17186 · Cited by 127
“They possess potent cytotoxic properties while at the same time functioning as cytokine-producing cells.(26) NK cells infiltrate into tissues and kill pathogen-infected, malignant or stressed cells.”
BackgroundSurgery-mediated tumor-promoting effects on the immune microenvironment
Cheng, X., Zhang, H., Hamad, A., Huang, H., & Tsung, A. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.01.006 · Cited by 135
Lymphocytes and innate immune cells in acute kidney injury and repair
Lee, K., Jang, H. R., & Rabb, H. (2024) · Nature Reviews Nephrology · doi:10.1038/s41581-024-00875-5 · Cited by 136
“NK cells are large granular lymphocytes that contain protease and pore-forming proteins and have the ability to recognize damaged cells 93 .”
Natural killer (NK) cells augment atherosclerosis by cytotoxic-dependent mechanisms
Selathurai, A., Deswaerte, V., Kanellakis, P., Tipping, P. G., Toh, B., Bobik, A., & Kyaw, T. S. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu016 · Cited by 136
“derived lymphocytes that act as effectors, through cell-mediated cytotoxicity, by releasing perforin and granzymes and/or cytokines such as interferon-g (IFN-g).(2) NK cells sense pathological changes or stressed cells via activating receptors.”
BackgroundMattiola, I., Pesant, M., Tentorio, P., Molgora, M., Marcenaro, E., Lugli, E., Locati, M., & Mavilio, D. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500325 · Cited by 136
“A proper activation of NK cells can be achieved with different proinflammatory cytokines, such as IL-2, IL-12, IL-15, IL-18, and type I IFNs (1, 21, 22).”
BackgroundInfluentialUnderstanding the cellular interactome of non-alcoholic fatty liver disease
Wallace, S. J., Tacke, F., Schwabe, R. F., & Henderson, N. C. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100524 · Cited by 116
“blasts that fail to enter senescence and continue to produce scar tissue are resistant to NK activity and perpetuate fibrosis even after the inflammatory stimulus has reduced.(84,85) Moreover, NK cells, via crosstalk with macrophages, attenuate NAFLD-induced fibrosis by regulating M1/M2 polarisation.”
BackgroundHuman NK Cells Induce Neutrophil Apoptosis via an NKp46- and Fas-Dependent Mechanism
Thorén, F. B., Riise, R. E., Ousbäck, J., Chiesa, M. D., Alsterholm, M., Marcenaro, E., Pesce, S., Prato, C., Cantoni, C., Bylund, J., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102002 · Cited by 123
“in recent years, NK cells have been shown to display immunomodulatory functions (9, 10).”
BackgroundMüller, S., Bexte, T., Gebel, V., Kalensee, F., Stolzenberg, E., Hartmann, J., Koehl, U., Schambach, A., Wels, W. S., Modlich, U., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03123 · Cited by 115
“Therefore, a combination of CD19-CARNK cells possessing ADCC with the anti-CD20 monoclonal antibody Rituximab may provide a treatment option for aggressive relapsed CD19+ and CD20+ B-ALL.”
BackgroundInfluentialMiyake, T., Kumagai, Y., Kato, H., Guo, Z., Matsushita, K., Satoh, T., Kawagoe, T., Kumar, H., Jang, M. H., Kawai, T., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901500 · Cited by 115
Li, F., Zhu, H., Sun, R., Wei, H., & Tian, Z. (2011) · Journal of Virology · doi:10.1128/jvi.06209-11 · Cited by 129
“NK cells can promote tissue immune injury through NKG2D, an activating receptor on NK cells, during viral infection (3, 32).”
BackgroundNatural killer cell immunotherapies against cancer: checkpoint inhibitors and more
Chiossone, L., Vienne, M., Kerdiles, Y. M., & Vivier, É. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.08.003 · Cited by 125
Bi, S., Jing, Y., Zhou, Q., Hu, X., Zhu, J., Guo, Z., Song, L., & Yu, R. (2018) · Food & Function · doi:10.1039/c7fo01147d · Cited by 120
Hensel, J. A., Khattar, V., Ashton, R., & Ponnazhagan, S. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0137-1 · Cited by 150
Arvindam, U. S., van Hauten, P. M. M., Schirm, D. K., Schaap, N. P., Hobo, W. A., Blazar, B. R., Vallera, D. A., Dolstra, H., Felices, M., & Miller, J. S. (2020) · Leukemia · doi:10.1038/s41375-020-01065-5 · Cited by 122
“Several studies have shown that activation of NK cells with IL-15 improves CD16 mediated ADCC activity in vitro and in vivo(37,38).”
Single-cell transcriptomics of the naked mole-rat reveals unexpected features of mammalian immunity
Hilton, H. G., Rubinstein, N. D., Janki, P., Ireland, A. T., Bernstein, N., Fong, N. L., Wright, K. M., Smith, M., Finkle, D., Martin-McNulty, B., et al. (2019) · PLOS Biology · doi:10.1371/journal.pbio.3000528 · Cited by 114
“16 Most vertebrate species have a population of innate lymphocytes that recognize and remove virally infected or malignantly transformed cells (33).”
BackgroundTrispecific natural killer cell nanoengagers for targeted chemoimmunotherapy
Au, K. M., Park, S. I., & Wang, A. Z. (2020) · Science Advances · doi:10.1126/sciadv.aba8564 · Cited by 118
Tumor-associated neutrophils suppress antitumor immunity of NK cells through the PD-L1/PD-1 axis
Sun, R., Xiong, Y.-Y., Liu, H., Gao, C., Su, L., Weng, J., Yuan, X., Zhang, D., & Feng, J. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100825 · Cited by 119
Hepatitis Virus Infection Affects DNA Methylation in Mice With Humanized Livers
Okamoto, Y., Shinjo, K., Shimizu, Y., Sano, T., Yamao, K., Gao, W., Fujii, M., Osada, H., Sekido, Y., Murakami, S., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.10.056 · Cited by 122
Natural killer cells in human autoimmunity.
Flodström-Tullberg, M., Bryceson, Y., Shi, F.-D., Höglund, P., & Ljunggren, H. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.09.012 · Cited by 123
Regulatory NK cells in autoimmune disease
Tian, Z., Gershwin, M. E., & Zhang, C. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.05.006 · Cited by 128
Li, Y., Zhang, J., Zhang, D., Hong, X., Yu, T., Wang, S., Xu, Y., Piao, H., Yin, W., Yu, M., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aah4323 · Cited by 117
“These findings provide new insights into the mechanism of RM and the versatility of NK cells (44).”
BackgroundRecent advances in regenerative medicine strategies for cancer treatment
Mansouri, V., Beheshtizadeh, N., Gharibshahian, M., Sabouri, L., Varzandeh, M., & Rezaei, N. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111875 · Cited by 121
Regulation of the innate immune system by autophagy: neutrophils, eosinophils, mast cells, NK cells
Germič, N., Frangež, Ž., Yousefi, S., & Simon, H. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0295-8 · Cited by 118
Zhao, Z., Ding, Y., Tran, L. J., Chai, G., & Li, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1196892 · Cited by 128
“NK cells, as lymphocytes of the innate immune system, hold essential importance and play a crucial role in antitumor responses (14).”
BackgroundZheng, Y., Sun, L., Guo, J., & Ma, J. (2023) · 癌症:英文版 · doi:10.1002/cac2.12487 · Cited by 125
“NK cells play a crucial role in the body’s defense against tumors [30].”
Metadata
- Authors
- Vivier, E., Tomasello, E., Baratin, M., Walzer, T., & Ugolini, S.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Venue
- Nature Immunology
- Published
- 2008-04-18
- Volume
- 9
- Issue
- 5
- Pages
- 503-510
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2073300038
- Cited by
- 3,943
- References
- 109
- Citations by year
- 2026: 195 · 2025: 269 · 2024: 299 · 2023: 292 · 2022: 302 · 2021: 332 · 2020: 260 · 2019: 271 · 2018: 224 · 2017: 247 · 2016: 202 · 2015: 195 · 2014: 159 · 2013: 156 · 2012: 141
- FWCI
- 9.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- European Commission
- Agence Nationale de la Recherche
- Institut National de la Santé et de la Recherche Médicale
- Ministère de l'Enseignement Supérieur et de la Recherche
- Centre National de la Recherche Scientifique
- Institut Universitaire de France
- Institut National Du Cancer
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- natural killer cells, innate immunity, tumor control, microbial infection, regulatory function, dendritic cells, macrophages, T cells, endothelial cells, immune regulation, hematopoietic stem cell transplantation, solid organ transplantation, cancer immunotherapy, inflammation, autoimmune disease
- MeSH terms
- Animals, Autoimmune Diseases, Dendritic Cells, Host vs Graft Reaction, Humans, Immune Tolerance, Inflammation, Killer Cells, Natural, Macrophages, Neoplasms, T-Lymphocytes, Virus Diseases, Immunotherapy, Adoptive, Endothelial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.